South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin

Fatemah Thawer-Esmail; Ivone Jakasa; Gail Todd; Yaran Wen; Sara J. Brown; Karin Kroboth; Linda E. Campbell; Grainne M. O'Regan; W. H. Irwin McLean; Alan D. Irvine; Sanja Kezic; Aileen Sandilands

doi:10.1016/j.jaci.2013.09.053

South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin

Fatemah Thawer-Esmail, Ivone Jakasa, Gail Todd, Yaran Wen, Sara J. Brown, Karin Kroboth, Linda E. Campbell, Grainne M. O'Regan, W. H. Irwin McLean, Alan D. Irvine, Sanja Kezic, Aileen Sandilands

Research output: Contribution to journal › Letter › peer-review

59 Citations (Scopus)

Original language	English
Pages (from-to)	280-282.e1-e2
Number of pages	5
Journal	Journal of Allergy and Clinical Immunology
Volume	133
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2013.09.053
Publication status	Published - Jan 2014

Access to Document

10.1016/j.jaci.2013.09.053

Dermatology and Genetic Medicine (Strategic Grant) (Joint with Kings College London)
Barton, G., Campbell, P., Hickerson, R., Leigh, I., McLean, I. & Wyatt, P.
Wellcome Trust
1/08/12 → 30/04/19
Project: Research

Cite this

Thawer-Esmail, F., Jakasa, I., Todd, G., Wen, Y., Brown, S. J., Kroboth, K., Campbell, L. E., O'Regan, G. M., McLean, W. H. I., Irvine, A. D., Kezic, S., & Sandilands, A. (2014). South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin. Journal of Allergy and Clinical Immunology, 133(1), 280-282.e1-e2. https://doi.org/10.1016/j.jaci.2013.09.053

@article{17ed08469cfe4b6f9df1ae313f320c8c,

title = "South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin",

author = "Fatemah Thawer-Esmail and Ivone Jakasa and Gail Todd and Yaran Wen and Brown, {Sara J.} and Karin Kroboth and Campbell, {Linda E.} and O'Regan, {Grainne M.} and McLean, {W. H. Irwin} and Irvine, {Alan D.} and Sanja Kezic and Aileen Sandilands",

year = "2014",

month = jan,

doi = "10.1016/j.jaci.2013.09.053",

language = "English",

volume = "133",

pages = "280--282.e1--e2",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "1",

}

Thawer-Esmail, F, Jakasa, I, Todd, G, Wen, Y, Brown, SJ, Kroboth, K, Campbell, LE, O'Regan, GM, McLean, WHI, Irvine, AD, Kezic, S & Sandilands, A 2014, 'South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin', Journal of Allergy and Clinical Immunology, vol. 133, no. 1, pp. 280-282.e1-e2. https://doi.org/10.1016/j.jaci.2013.09.053

South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin. / Thawer-Esmail, Fatemah; Jakasa, Ivone; Todd, Gail et al.
In: Journal of Allergy and Clinical Immunology, Vol. 133, No. 1, 01.2014, p. 280-282.e1-e2.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin

AU - Thawer-Esmail, Fatemah

AU - Jakasa, Ivone

AU - Todd, Gail

AU - Wen, Yaran

AU - Brown, Sara J.

AU - Kroboth, Karin

AU - Campbell, Linda E.

AU - O'Regan, Grainne M.

AU - McLean, W. H. Irwin

AU - Irvine, Alan D.

AU - Kezic, Sanja

AU - Sandilands, Aileen

PY - 2014/1

Y1 - 2014/1

U2 - 10.1016/j.jaci.2013.09.053

DO - 10.1016/j.jaci.2013.09.053

M3 - Letter

C2 - 24369804

SN - 0091-6749

VL - 133

SP - 280-282.e1-e2

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -

South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin

Access to Document

Projects

Dermatology and Genetic Medicine (Strategic Grant) (Joint with Kings College London)

Cite this